More marketing and potential hidden information seems to be making it's way to front, and interesting now on who wants to be reimbursed, insurance companies among the group. This appears to be an all out battle ground here. Weight gain and diabetes as side effects? Class action law suits can be very costly and with all the groups named within, I'm sure the story on this one will be in the news for a while. 
With the age of transparency it certainly is bringing more information to the spotlight as we all now are in the position to find out much more about the drugs we have been taking and how they got to market in the first place, and somewhere in all of this the information supplied to the FDA just might find a way in here as well as relating to consumer safety. BD
Eli Lilly will face a class-action suit over Zyprexa, now that a federal judge has certified a group of insurance companies, pension funds, and unions that want the drugmaker to repay them for the billions they spent on the controversial antipsychotic drug. The plaintiffs allege that Lilly hid the drug's side effects--including excessive weight gain and diabetes--and marketed it for off-label uses. The judge, Jack Weinstein, said in his 295-page ruling that the plaintiffs have presented "sufficient evidence of fraud under RICO," the Racketeer Influenced and Corrupt Organizations Act originally designed to prosecute organized crime but now often used in corporate cases.
0 comments :
Post a Comment